Skip to content
Aussie8 – Lifestyle
Author:
Nasus Pharma, Ltd.
Nasus Pharma Advances NS002 Towards Pivotal Study Following Positive Phase 2; Reports Annual Results and Provides Business Update
March 25, 2026
Nasus Pharma to Present and Participate in the Upcoming Life Sciences Investor Forum
March 9, 2026
←
Previous Page
1
2